{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:30:55Z","timestamp":1793442655208,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115432","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:22:21Z","timestamp":1790954541000},"page":"115432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Extracellular vesicles: rising stars among drug delivery systems?"],"prefix":"10.1016","volume":"399","author":[{"given":"Volkmar","family":"Weissig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","article-title":"Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115432_bb0010","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ymthe.2023.02.013","article-title":"Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading","volume":"31","author":"Radler","year":"2023","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115432_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0021-9258(17)34997-9","article-title":"The biological significance of the thromboplastic protein of blood","volume":"166","author":"Chargaff","year":"1946","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115432_bb0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","article-title":"The nature and significance of platelet products in human plasma","volume":"13","author":"Wolf","year":"1967","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0005-2736(81)90512-5","article-title":"Exfoliation of membrane ecto-enzymes in the form of micro-vesicles","volume":"645","author":"Trams","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115432_bb0035","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","article-title":"Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)","volume":"262","author":"Johnstone","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115432_bb0040","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev-genet-111523-102725","article-title":"The nature and nurture of extracellular vesicle-mediated signaling","volume":"58","author":"Buck","year":"2024","journal-title":"Annu. Rev. Genet."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115432_bb0050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/tra.12687","article-title":"Exosomes: revisiting their role as \u201cgarbage bags\u201d","volume":"20","author":"Vidal","year":"2019","journal-title":"Traffic"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115432_bb0055","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115432_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"17","key":"10.1016\/j.jconrel.2026.115432_bb0065","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1093\/nar\/gks463","article-title":"Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes","volume":"40","author":"Wahlgren","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/mt.2012.180","article-title":"Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells","volume":"21","author":"Ohno","year":"2013","journal-title":"Mol. Ther."},{"issue":"Pt A","key":"10.1016\/j.jconrel.2026.115432_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2016.10.004","article-title":"ADDR editorial \u201cbiologically-inspired drug delivery systems\u201d","volume":"106","author":"Vader","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Pt A","key":"10.1016\/j.jconrel.2026.115432_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","article-title":"Extracellular vesicles for drug delivery","volume":"106","author":"Vader","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115432_bb0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.phrs.2016.07.006","article-title":"Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: new nanotools for cancer treatment","volume":"111","author":"Kooijmans","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"7659","key":"10.1016\/j.jconrel.2026.115432_bb0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115432_bb0095","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.2147\/IJN.S225453","article-title":"Extracellular vesicles as nanomedicine: hopes and hurdles in clinical translation","volume":"14","author":"Burnouf","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115432_bb0100","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115432_bb0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejpb.2020.07.026","article-title":"Exosomes as drug delivery systems: a brief overview and progress update","volume":"154","author":"Patil","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12951-023-01973-5","article-title":"Extracellular vesicles: a rising star for therapeutics and drug delivery","volume":"21","author":"Du","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115432_bb0115","article-title":"Guidelines for clinical translation and commercialization of extracellualr evsicles and exosomes based therapeutics","volume":"2","author":"Cheng","year":"2023","journal-title":"Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115432_bb0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1021\/acsbiomaterials.2c01329","article-title":"Exosome-based smart drug delivery tool for cancer theranostics","volume":"9","author":"Kar","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115432_bb0125","article-title":"Extracellular vesicles as novel drug-delivery systems through intracellular communications","volume":"12","author":"Matsuzaka","year":"2022","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.jconrel.2026.115432_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1307878","article-title":"Extracellular vesicles and exosome-like nanovesicles as pioneering oral drug delivery systems","volume":"11","author":"Mondal","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115432_bb0135","first-page":"1","article-title":"Signature of click chemistry in exosome modification for cancer therapeutic","volume":"4","author":"Mukerjee","year":"2024","journal-title":"Clin. Transl. Disc."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115432_bb0140","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM197609232951305","article-title":"The carrier potential of liposomes in biology and medicine (first of two parts)","volume":"295","author":"Gregoriadis","year":"1976","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.jconrel.2026.115432_bb0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM197609302951406","article-title":"The carrier potential of liposomes in biology and medicine (second of two parts)","volume":"295","author":"Gregoriadis","year":"1976","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115432_bb0150","doi-asserted-by":"crossref","first-page":"58P","DOI":"10.1042\/bj1240058P","article-title":"Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases","volume":"124","author":"Gregoriadis","year":"1971","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115432_bb0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0014-5793(71)80109-6","article-title":"Enzyme entrapment in liposomes","volume":"14","author":"Gregoriadis","year":"1971","journal-title":"FEBS Lett."},{"issue":"7870","key":"10.1016\/j.jconrel.2026.115432_bb0160","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(74)90682-5","article-title":"Drug-carrier potential of liposomes in cancer chemotherapy","volume":"1","author":"Gregoriadis","year":"1974","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115432_bb0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.122.2.585","article-title":"Binding of antigen-bearing fluorescent liposomes to the murine myeloma tumor MOPC 315","volume":"122","author":"Leserman","year":"1979","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115432_bb0170","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1073\/pnas.77.7.4089","article-title":"Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells","volume":"77","author":"Leserman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5791","key":"10.1016\/j.jconrel.2026.115432_bb0175","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/288602a0","article-title":"Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A","volume":"288","author":"Leserman","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115432_bb0180","series-title":"Liposomes: A Practical Approach","year":"2003"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115432_bb0185","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/bc050308l","article-title":"Targeted liposomes: convenient coupling of ligands to preformed vesicles using \u201cclick chemistry\u201d","volume":"17","author":"Said Hassane","year":"2006","journal-title":"Bioconjug. Chem."},{"issue":"14","key":"10.1016\/j.jconrel.2026.115432_bb0190","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115432_bb0195","article-title":"Targeted liposomal drug delivery: overview of the current applications and challenges","volume":"14","author":"Gatto","year":"2024","journal-title":"Life (Basel)"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115432_bb0200","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115432_bb0205","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2147\/IJN.S46900","article-title":"Nanopharmaceuticals (part 1): products on the market","volume":"9","author":"Weissig","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115432_bb0210","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s44222-025-00277-7","article-title":"Extracellular vesicles for the delivery of gene therapy","volume":"3","author":"Di Ianni","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"issue":"162","key":"10.1016\/j.jconrel.2026.115432_bb0215","first-page":"54220","article-title":"Draft guidance for industry on liposome products: chemistry, manufacturing, and controls; human pharmacokinetics and bioavailability; and labeling documentation; availability","volume":"67","author":"Hubbard","year":"2002","journal-title":"Fed. Regist."},{"key":"10.1016\/j.jconrel.2026.115432_bb0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2019.05.010","article-title":"Ligand density on nanoparticles: a parameter with critical impact on nanomedicine","volume":"143","author":"Alkilany","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115432_bb0225","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2012.05.042","article-title":"Challenges in design of translational nanocarriers","volume":"164","author":"Sun","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0230","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115432_bb0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"33","key":"10.1016\/j.jconrel.2026.115432_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202403199","article-title":"Immunogenicity of extracellular vesicles","volume":"36","author":"Xia","year":"2024","journal-title":"Adv. Mater."},{"issue":"5480","key":"10.1016\/j.jconrel.2026.115432_bb0245","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/252252a0","article-title":"Liposomes as immunological adjuvants","volume":"252","author":"Allison","year":"1974","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0250","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0014-5793(86)80654-8","article-title":"A new hydrophobic anchor for the attachment of proteins to liposomal membranes","volume":"202","author":"Weissig","year":"1986","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0255","first-page":"56","article-title":"A method for preparation of liposomes with encapsulated peptide antigens and surface-linked sugar residues","volume":"46","author":"Weissig","year":"1991","journal-title":"Pharmazie"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0260","first-page":"25","article-title":"Comparison of the immune response against polio peptides covalently-surface-linked to and internally-entrapped in liposomes","volume":"9","author":"Tan","year":"1991","journal-title":"Asian Pac. J. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115432_bb0265","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115432_bb0270","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)29419-2","article-title":"Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection","volume":"298","author":"Laverman","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0275","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"17","key":"10.1016\/j.jconrel.2026.115432_bb0280","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.99.17.2302","article-title":"Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody","volume":"99","author":"Szebeni","year":"1999","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115432_bb0285","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41565-025-01877-5","article-title":"The pathways for nanoparticle transport across tumour endothelium","volume":"20","author":"Wu","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115432_bb0290","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/acs.accounts.6c00062","article-title":"Enhanced transcytosis and retention (ETR) of drug delivery nanocarrier in solid tumors","volume":"59","author":"Qin","year":"2026","journal-title":"Acc. Chem. Res."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115432_bb0295","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","article-title":"Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models","volume":"66","author":"Kirpotin","year":"2006","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.jconrel.2026.115432_bb0300","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1039\/c3cc37307j","article-title":"Protein corona significantly reduces active targeting yield","volume":"49","author":"Mirshafiee","year":"2013","journal-title":"Chem. Commun. (Camb.)"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115432_bb0305","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1432-1033.1972.tb19710.x","article-title":"Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases","volume":"24","author":"Gregoriadis","year":"1972","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0310","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2026.115432_bb0315","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.2147\/IJN.S444582","article-title":"Engineered exosome for drug delivery: recent development and clinical applications","volume":"18","author":"Tian","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115432_bb0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2736(93)90105-9","article-title":"Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases","volume":"1151","author":"Haran","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115432_bb0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0330","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/bj1290123","article-title":"Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats","volume":"129","author":"Gregoriadis","year":"1972","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115432_bb0335","first-page":"239","article-title":"Liposomes as carriers of DNA","volume":"6","author":"Nicolau","year":"1989","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"21","key":"10.1016\/j.jconrel.2026.115432_bb0340","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.jconrel.2026.115432_bb0345","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115432_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-2954-3_1","article-title":"From olive oil emulsions to COVID-19 vaccines: liposomes came first","volume":"2622","author":"Weissig","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115432_bb0355","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115432_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1363185","article-title":"Defining tropism and activity of natural and engineered extracellular vesicles","volume":"15","author":"Choi","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0365","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12951-024-02315-9","article-title":"Hydrogel-mediated extracellular vesicles for enhanced wound healing: the latest progress, and their prospects for 3D bioprinting","volume":"22","author":"Zheng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115432_bb0370","article-title":"Extracellular vesicle-loaded hydrogels for tissue repair and regeneration","volume":"18","author":"Ju","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115432_bb0375","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-026-04236-1","article-title":"Hydrogel-extracellular vesicle engineering delivery system: a promising therapeutic strategy for wound healing","volume":"24","author":"Gao","year":"2026","journal-title":"J. Nanobiotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:41:36Z","timestamp":1793439696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":75,"alternative-id":["S0168365926008369"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115432","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles: rising stars among drug delivery systems?","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115432"}}